78796-0
LaboratoryAtazanavir [Mass/volume] in Amniotic fluid
Definition
Atazanavir, unlike other protease inhibitor used to treat HIV infection, crosses the placenta and when boosted with ritonavir (RTV) achieves measurable concentrations in the fetus. The risks and/or benefits of newborn exposure are not known.[PMID: 19053892] Measurement of antiretroviral medication concentration in amniotic fluid may be needed to identify signals of subtherapeutic or supratherapeutic drug exposure.
LOINC 6-Axis Classification
Component
Atazanavir
Property
MCnc
Time Aspect
Pt
System
Amnio fld
Scale Type
Qn
Method Type
N/A
Details
Class
DRUG/TOX
Order/Observation
Both
Short Name
Atazanavir Amn-mCnc
Display Name
Atazanavir (Amn fld) [Mass/Vol]
Related Names
Frequently Asked Questions
What is LOINC code 78796-0?
LOINC code 78796-0 identifies "Atazanavir [Mass/volume] in Amniotic fluid". Atazanavir, unlike other protease inhibitor used to treat HIV infection, crosses the placenta and when boosted with ritonavir (RTV) achieves measurable concentrations in the fetus. The risks and/or benefits of newborn exposure are not known.[PMID: 19053892] Measurement of antiretroviral medication concentration in amniotic fluid may be needed to identify signals of subtherapeutic or supratherapeutic drug exposure.
What does 78796-0 measure?
This code measures Atazanavir in Amnio fld. It belongs to the DRUG/TOX class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.